BCHMF (Bachem Holding AG) ROCE %: 12.22% (As of Dec. 2025)


BCHMF Bachem Holding AG BCHMF
91 GF Score
Price $87.34
GF Value $98.06
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bachem Holding AG ROCE %?

Bachem Holding AG BCHMF 91 ROCE % is 12.22% as of Dec. 2025. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $98.06 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bachem Holding AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.22%.

Bachem Holding AG  (OTCPK:BCHMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bachem Holding AG ROCE % Related Terms

Bachem Holding AG ROCE % Historical Data

* Premium members only.

The historical data trend for Bachem Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bachem Holding AG ROCE % Chart

Bachem Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.99 9.36 9.38 8.43 9.89

Bachem Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.61 5.28 12.06 7.23 12.22
BCHMF
91GF Score
Bachem Holding AG BCHMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bachem Holding AG ROCE % Calculation

Bachem Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=196.759/( ( (2156.764 - 315.151) + (2646.16 - 508.789) )/ 2 )
=196.759/( (1841.613+2137.371)/ 2 )
=196.759/1989.492
=9.89 %

Bachem Holding AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=252.22/( ( (2349.757 - 358.53) + (2646.16 - 508.789) )/ 2 )
=252.22/( ( 1991.227 + 2137.371 )/ 2 )
=252.22/2064.299
=12.22 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.22% mean?
Bachem Holding AG (BCHMF) has a ROCE % of 12.22% as of Dec. 2025.
Is Bachem Holding AG's ROCE % too high?
Bachem Holding AG's current ROCE % is 12.22%. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's ROCE % compare to VRTX and REGN?
Bachem Holding AG's ROCE % of 12.22% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Bachem Holding AG's current ROCE % is 12.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.06, compared to a current price of $87.34 — trading 10.9% below its estimated fair value. The current ROCE % is 12.22%. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current ROCE % is 12.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bachem Holding AG (BCHMF) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of $87.34 is trading 10.9% below its estimated GF Value™ of $98.06. GuruFocus considers Bachem Holding AG to be Modestly Undervalued.

Key valuation signals for BCHMF:

  • ROCE %: 12.22%
  • GF Value™: $98.06 vs. price of $87.34 (10.9% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score

Get the complete analysis for BCHMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$87.34
Price
$98.06
GF Value